Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.65 |
| ▸ | MAOB | P27338 | 3/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.51 |
| ▸ | AR | P10275 | 8/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9745473 | 1.00 | ALDH1A1 (0.65) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL9747026 | 1.00 | ALDH1A1 (0.65) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL9745656 | 0.96 | ALDH1A1 (0.61) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL9746267 | 0.96 | ALDH1A1 (0.61) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL9746946 | 0.96 | ALDH1A1 (0.61) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL5143806 | 0.96 | ALDH1A1 (0.61) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL9747762 | 0.96 | ALDH1A1 (0.61) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL28487747 | 0.92 | ALDH1A1 (0.57) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL13908822 | 0.92 | CYP19A1 (0.65) | ALDH1A1HPGDCYP19A1MAOBNPSR1 | |
| SCHEMBL1377229 | 0.92 | CYP19A1 (0.62) | ALDH1A1HPGDCYP19A1MAOBNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3965738-B1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIV DO MINHO (PT) | 2025-08-06 | — | — | EP | disclosed |
| EP-3877447-B1 | COMPOSITION OF PHTHALONITRILE RESIN MATRIX FOR POLYMER COMPOSITE MATERIALS, METHOD FOR FABRICATION THEREOF, METHOD FOR MANUFACTURING OF POLYMER COMPOSITE MATERIAL, AND MATERIAL OBTAINED BY THIS METHOD | JOINT STOCK COMPANY (RU) | 2024-07-17 | — | — | EP | disclosed |
| CN-117736232-A | Green synthesis method of high-yield alpha (beta) -tetra-substituent-dihydroxyl silicon phthalocyanine derivative | 浙江工业大学 | 2024-03-22 | — | — | CN | disclosed |
| US-20240018109-A1 | METHOD FOR SYNTHESIS OF ROXADUSTAT AND INTERMEDIATE THEREOF, AND INTERMEDIATE THEREOF | JUMPCAN (SHANGHAI) MEDICAL TECHNOLOGY CO., LTD (CN) | 2024-01-18 | — | — | US | disclosed |
| US-20240018109-A1 | METHOD FOR SYNTHESIS OF ROXADUSTAT AND INTERMEDIATE THEREOF, AND INTERMEDIATE THEREOF | JUMPCAN (SHANGHAI) MEDICAL TECHNOLOGY CO., LTD (CN) | 2024-01-18 | — | — | US | disclosed |
| EP-3705541-B1 | THREE-DIMENSIONAL PRINTING INK COMPRISING PHTHALONITRILE OLIGOMER | LG CHEMICAL LTD (KR) | 2023-09-06 | — | — | EP | disclosed |
| US-20230183180-A1 | PROCESS OF MAKING ROXADUSTAT | SUZHOU PENGXU PHARMATECH CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-11674045-B2 | Three-dimensional printing ink comprising a phthalonitrile oligomer | LG CHEM, LTD (KR) | 2023-06-13 | — | — | US | disclosed |
| US-11674045-B2 | Three-dimensional printing ink comprising a phthalonitrile oligomer | LG CHEM, LTD (KR) | 2023-06-13 | — | — | US | disclosed |
| CN-110461814-B | Resin blends, prepregs and articles containing a phthalonitrile reactive diluent and a bisphthalonitrile resin | 3M创新有限公司 | 2023-04-14 | — | — | CN | disclosed |
| US-5149800-A | For natural or synthetic resins, especially polyolefins and polyurethane foams | MILLIKEN RESEARCH CORPORATION (US) | 1992-09-22 | — | — | US | disclosed |
| US-5135717-A | Imaging therapy | BRITISH TECHNOLOGY GROUP USA INC. (US) | 1992-08-04 | — | — | US | disclosed |
| US-5135972-A | For polymeric substrates | MILLIKEN RESEARCH CORPORATION (US) | 1992-08-04 | — | — | US | disclosed |
| EP-0484027-A1 | Polysubstituted phthalocyanines | ZENECA LIMITED (GB) | 1992-05-06 | — | — | EP | disclosed |
| EP-0434727-A1 | RED-SHIFTED PHTHALOCYANINE AND TETRABENZTRIAZAPORPHYRIN REAGENTS | BRITISH TECHNOLOGY GROUP (USA) INCORPORATED (US) | 1991-07-03 | — | — | EP | disclosed |
| EP-0398620-A2 | Poly(oxyalkylene) modified phthalocyanine colorants | MILLIKEN RESEARCH CORPORATION (US) | 1990-11-22 | — | — | EP | disclosed |
| WO-1990002747-A1 | RED-SHIFTED PHTHALOCYANINE AND TETRABENZTRIAZAPORPHYRIN REAGENTS | ULTRA DIAGNOSTICS CORPORATION (US) | 1990-03-22 | — | — | WO | disclosed |
| US-4587325-A | N-HETEROCYCLE POLYMERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1986-05-06 | — | — | US | disclosed |
| US-4145264-A | AROMATIC O-DICARBOXYLIC ACID NITRILES ELECTROLYZED IN AN ORGANIC LIQUID WITH AN ALKALINE ACTIVATOR | BASF AKTIENGESELLSCHAFT (DE) | 1979-03-20 | — | — | US | disclosed |
| US-3994921-A | COLORING PLASTICS AND LACQUERS YELLOW | CIBA-GEIGY CORPORATION (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183180-A1 | PROCESS OF MAKING ROXADUSTAT | CYP2B6, UGT1A6, CYP2D6 | ALDH1A1 752/4885HPGD 298/4885CYP19A1 77/4885 |
| US-20240018109-A1 | METHOD FOR SYNTHESIS OF ROXADUSTAT AND INTERMEDIATE THEREOF, AND INTERMEDIATE THEREOF | SRM, SMS, SMOX | ALDH1A1 101/4885HPGD 642/4885CYP19A1 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.